| SENSEONICS HLGS.INC. NEW |
| USA |
| Gesundheit |
| US81727U3032 / A41MRZ |
| 6L60 (Frankfurt) / SENS (NASDAQ) |
| FRA:6L60, ETR:6L60, 6L60:GR, NASDAQ:SENS |
| - |
| https://www.senseonics.co.. |
|
Senseonics Holdings Inc. is a medical technology company focused on long-term implantable continuous glucose monitoring systems for people with diabetes. Its Eversense product line combines a small under-the-skin sensor, a removable smart transmitter..
>Volltext.. |
| 428.04 Mio. EUR |
| 357.83 Mio. EUR |
| 41.9 Mio. EUR |
| -91.92 Mio. EUR |
| -94.41 Mio. EUR |
| -1.97 EUR |
| 54.22 Mio. EUR |
| 38.9 Mio. EUR |
| -83.16 Mio. EUR |
| 5.79 |
| 96.62% |
| -65.41% |
| - |
| - |
| - |
| SENSEONICS |
| 06.09.26 |
|